ACIP Update Targets RSV, Pneumococcal and Influenza Vaccines in Children
ACIP recommends use of nirsevimab to prevent RSV in all infants, pediatric use of the 20-valent pneumococcal conjugate vaccine, and wider use of influenza vaccines.
Vaccine Information Center
FDA Greenlights Updated COVID-19 Vaccines; Bivalent Vaccines No Longer Authorized
The bivalent Pfizer-BioNTech and Moderna COVID-19 vaccines are no longer authorized for use in the United States.
ACIP: Updated Vaccine Guidance for the 2023-2024 Influenza Season
Primary updates include the composition of the 2023-2024 vaccine, as well as new guidance for patients with egg allergy.
Immunization Update: 2024 Vaccine Schedules for Infants, Children, and Adolescents
After sharp declines during the COVID-19 pandemic, vaccination rates among children are rising but vaccine hesitancy continues among many parents.
Moderna’s Updated COVID-19 Vaccine Appears Effective Against Rapidly Spreading Variants
Moderna says it will be ready to provide the updated vaccine for the upcoming fall vaccination season once authorized by the FDA.
RSV Vaccine Abrysvo Approved for Use During Pregnancy to Protect Infants
Abyrsvo is the first vaccine approved for pregnant individuals to prevent RSV disease in infants.
Education on Approval Process May Increase Acceptance of New RSV Vaccines
Those educated on vaccine approval process or about potential severity of RSV may be more accepting.
Ebola Vaccine Indication Expanded to Include Use in Children
The duration of protection conferred by Ervebo is unknown.
Third Dose of COVID-19 Vaccine Seems Safe for Young Children
No new safety concerns reported among children aged 6 months to 5 years receiving third dose of mRNA COVID-19 vaccine.
RSV Vaccine Abrysvo Approved for Individuals 60 Years and Older
Abrysvo is expected to be available in the third quarter of 2023.
RSV Vaccine: 4 Questions Answered
The world’s first RSV vaccine could be rolled out by fall 2023, in time for the typical winter surge in RSV infections.
Is There an HIV Vaccine?
May 18 is HIV Vaccine Day, created to promote awareness of HIV vaccine research. What is the current state of vaccines for preventing HIV and how have recent trials gone?
RSV Vaccine Arexvy Wins FDA Approval for Older Adults
Arexvy is expected to be available for the 2023-2024 RSV season.
Human Metapneumovirus, or HMPV, Is Filling ICUs This Spring
A pediatric infectious disease specialist explains this little-known virus.
Pfizer-BioNTech Bivalent Booster Authorized for Kids Under 5 Years
This age group is now eligible to receive the booster dose at least 2 months after they complete primary vaccination with 3 doses of the monovalent vaccine.
Lying and Vaccine Disinformation Among Parents
Approximately 25% of parents lie about their child’s COVID-19 vaccine status or don’t quarantine their children, survey findings show.
M-M-R II, Varivax, ProQuad Vaccines Approved for Intramuscular Administration
M-M-R II, Varivax, and ProQuad are supplied in single-dose vials as lyophilized vaccine for SC or IM injection after reconstitution.
Flu Vaccine Effective for 2022/2023 Season
Vaccine effectiveness 54% against medically attended outpatient acute respiratory infection associated with influenza A in patients younger than 65 years
ACIP: 2023 Adult Immunization Schedule Updates
Several changes have been made to the adult immunization schedule 2023.
ACIP: 2023 Child and Adolescent Immunization Schedule Updates
Several changes have been made to the child and adolescent immunization schedule for 2023.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Vaccine Information Center
Loading... 
Loading...